Tanner, BurnsAdler merge to form new Tanner Pharma Group

Tanner Pharma Group includes three complementary divisions Tanner Clinical Trial Sourcing (TannerCTS), Tanner Global Access Programs (TannerGAP) and Tanner Licensing, Acquisition and Commercialisation (TannerLAC).

The new firm’s complementary divisions offer single-point solutions for clients seeking clinical trial sourcing, global access programs and commercialization expertise in challenging global markets.

The newly formed entity is a portfolio company of Bourne Partners, a US-based healthcare-focused merchant bank that offers financial advisory, direct investment and management consulting services to life sciences partners worldwide.

Bourne Partners CEO Banks Bourne said: "We are pleased to announce this merger, which allows our pharmaceutical partners to retain the expertise and customer service that they have come to expect from both Tanner and BurnsAdler, while significantly enhancing our service offering and global reach.

"With the formation of Tanner Pharma Group, we continue to focus on improving the lives of patients by providing comprehensive solutions to both manufacturing partners, including big pharma, specialty pharma, biotech and consumer/OTC companies, as well as to in-market providers, such as governments, hospitals, clinics, pharmacies, physicians and patients themselves."

TannerCTS procures comparator products for manufacturers, CROs and research centers from a broad range of sources, TannerGAP serves manufacturers and providers by developing, implementing and managing Global Access Programs in international markets, while TannerLAC serves pharmaceutical, biotech and healthcare companies by maximizing commercial potential for their products in Latin America and other challenging markets.

Tanner Pharma Group Corporate Development director Josh Cooper said: "We began by licensing and owning products, then evolved into additional services.

"Our new structural alignment allows us to offer highly specialized services to our partners while leveraging our experience and quality standards across the entire platform."

According to a statement, current client-partners of Tanner Pharmaceuticals and BurnsAdler Pharmaceuticals can expect a seamless transition to the new organization, as all client contacts will remain the same.